| 臺大學術典藏 |
2021-02-02T02:22:24Z |
Endoscopic appearance of GI mycobacteriosis caused by the Mycobacterium avium complex in a patient with AIDS: Case report and review
|
Sun H.-Y.; Chen M.-Y.; MING-SHIANG WU; Hsieh S.-M.; Fang C.-T.; Hung C.-C.; Chang S.-C. |
| 臺大學術典藏 |
2021-01-27T01:38:09Z |
Disseminated mycobacterium abscessus infection and showerheads, Taiwan
|
Kuo Y.-M.;Cheng A.;Wu P.-C.;Hsieh S.-C.;Hsieh S.-M.;Hsueh P.-R.;Chia-Li Yu; Kuo Y.-M.; Cheng A.; Wu P.-C.; Hsieh S.-C.; Hsieh S.-M.; Hsueh P.-R.; CHIA-LI YU |
| 臺大學術典藏 |
2021-01-15T02:46:28Z |
Disseminated mycobacterium abscessus infection and showerheads, Taiwan
|
Kuo Y.-M.; Cheng A.; Wu P.-C.; SONG-CHOU HSIEH; Hsieh S.-M.; Hsueh P.-R.; Yu C.-L. |
| 臺大學術典藏 |
2021-01-14T03:09:06Z |
A clinical study to assess the immunogenicity and safety of a monovalent 2009 influenza A (H1N1) vaccine in an area with low-level epidemics of pandemic influenza
|
Kung H.-C.; KUO-CHIN HUANG; Kao T.-M.; Lee Y.-C.; Chang F.-Y.; Wang N.-C.; Liu Y.-C.; Lee W.-S.; Liu H.-J.; Chen C.-I.; Chen C.-H.; Huang L.-M.; Hsieh S.-M. |
| 臺大學術典藏 |
2021-01-14T03:09:06Z |
Immune response of single dose vaccination against 2009 pandemic influenza A (H1N1) in the Taiwanese elderly
|
Kao T.M.; Hsieh S.M.; Kung H.C.; Lee Y.C.; KUO-CHIN HUANG; Huang L.M.; Chang F.Y.; Wang N.C.; Liu Y.C.; Lee W.S.; Liu H.E.; Chen C.I.; Chen C.-H. |
| 臺大學術典藏 |
2021-01-14T03:09:03Z |
Persistence of immunogenicity of a monovalent influenza virus A/H1N1 2009 vaccine in healthy volunteers
|
Lai Y.-C.; Yang K.-C.; Hsieh S.-M.; Yao C.-A.; Lee L.-T.; KUO-CHIN HUANG |
| 臺大學術典藏 |
2021-01-08T02:16:23Z |
Safety and Immunogenicity of a Tetravalent Polysaccharide Vaccine Against Meningococcal Disease
|
Chang L.-Y.; Shao P.-L.; Shao P.-L.;Chang L.-Y.;Hsieh S.-M.;Chang S.-C.;Pan S.-C.;Chun-Yi Lu;Hsieh Y.-C.;Lee C.-Y.;Dobbelaere K.;Boutriau D.;Tang H.;Bock H.L.;Huang L.-M.; Huang L.-M.; Bock H.L.; Tang H.; Hsieh S.-M.; Chang S.-C.; Pan S.-C.; CHUN-YI LU; Hsieh Y.-C.; Lee C.-Y.; Dobbelaere K.; Boutriau D. |
| 國立成功大學 |
2021 |
Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan
|
Hsieh, S.-M.;Liu, M.-C.;Chen, Y.-H.;Lee, W.-S.;Hwang, S.-J.;Cheng, S.-H.;Ko, W.-C.;Hwang, K.-P.;Wang, N.-C.;Lee, Y.-L.;Lin, Y.-L.;Shih, Shih S.-R.;Huang, C.-G.;Liao, C.-C.;Liang, J.-J.;Chang, Chang C.-S.;Chen, Chen C.;Lien, C.E.;Tai, I.-C.;Lin, T.-Y. |
| 臺大學術典藏 |
2020-12-30T02:46:06Z |
Clinical experience of the 23-valent capsular polysaccharide pneumococcal vaccination in HIV-1-infected patients receiving highly active antiretroviral therapy: A prospective observational study
|
Chen M.-Y.; Hung C.-C.; Hung C.-C.;Chen M.-Y.;Hsieh S.-M.;Hsiao C.-F.;Sheng W.-H.;Shan-Chwen Chang; Hsieh S.-M.; Hsiao C.-F.; Sheng W.-H.; SHAN-CHWEN CHANG |
| 臺大學術典藏 |
2020-12-30T02:46:05Z |
A randomized, double-blind, controlled clinical trial to evaluate the safety and immunogenicity of an intranasally administered trivalent inactivated influenza vaccine with adjuvant LTh(αK): A phase I study
|
Pan S.-C.; Hsieh S.-M.; Lin C.-F.; Hsu Y.-S.; Chang M.; SHAN-CHWEN CHANG |
| 臺大學術典藏 |
2020-12-30T02:45:59Z |
Antithyroid-drug-induced agranulocytosis complicated by life-threatening infections
|
Hsieh S.-M.; SHAN-CHWEN CHANG; Hsieh W.-C.; Sheng W.-H.;Hung C.-C.;Chen Y.-C.;Fang C.-T.;Hsieh S.-M.;Shan-Chwen Chang;Hsieh W.-C.; Sheng W.-H.; Hung C.-C.; Chen Y.-C.; Fang C.-T. |
| 臺大學術典藏 |
2020-12-30T02:45:47Z |
Septic Candida krusei thrombophlebitis of inferior vena cava with persistent fungemia successfully treated by new antifungal agents
|
Pan S.-C.;Hsieh S.-M.;Shan-Chwen Chang;Lee H.-T.;Chen Y.-C.; Pan S.-C.; Hsieh S.-M.; SHAN-CHWEN CHANG; Lee H.-T.; Chen Y.-C. |
| 臺大學術典藏 |
2020-12-30T02:45:46Z |
Serological responses to revaccination against HBV in HIV-positive patients born in the era of nationwide neonatal HBV vaccination
|
Huang Y.-C.;Hsieh S.-M.;Sheng W.-H.;Huang Y.-S.;Lin K.-Y.;Chen G.-J.;Yang S.-P.;Liu W.-C.;Su Y.-C.;Sun H.-Y.;Hung C.-C.;Shan-Chwen Chang; Huang Y.-C.; Hsieh S.-M.; Sheng W.-H.; Huang Y.-S.; Lin K.-Y.; Chen G.-J.; Yang S.-P.; Liu W.-C.; Su Y.-C.; Sun H.-Y.; Hung C.-C.; SHAN-CHWEN CHANG |
| 臺大學術典藏 |
2020-12-30T02:45:46Z |
Serological responses to revaccination with hepatitis A virus (HAV) vaccines among HIV-positive individuals whose anti-HAV antibody waned after primary vaccination
|
Chen G.-J.;Sun H.-Y.;Lin K.-Y.;Cheng A.;Huang Y.-C.;Hsieh S.-M.;Sheng W.-H.;Liu W.-C.;Hung C.-C.;Shan-Chwen Chang; Chen G.-J.; Sun H.-Y.; Lin K.-Y.; Cheng A.; Huang Y.-C.; Hsieh S.-M.; Sheng W.-H.; Liu W.-C.; Hung C.-C.; SHAN-CHWEN CHANG |
| 臺大學術典藏 |
2020-12-30T02:45:46Z |
Incidence of acute hepatitis A among HIV-positive patients during an outbreak among MSM in Taiwan: Impact of HAV vaccination
|
Sun H.-Y.; Sheng W.-H.; Hsieh S.-M.; Huang Y.-C.; Cheng A.; Liu W.-C.; Hung C.-C.; SHAN-CHWEN CHANG; Chen G.-J.;Lin K.-Y.;Sun H.-Y.;Sheng W.-H.;Hsieh S.-M.;Huang Y.-C.;Cheng A.;Liu W.-C.;Hung C.-C.;Shan-Chwen Chang; Chen G.-J.; Lin K.-Y. |
| 臺大學術典藏 |
2020-12-30T02:45:39Z |
Clinical features of tuberculosis associated with HIV infection in Taiwan
|
Hsieh S.-M.;Hung C.-C.;Chen M.-Y.;Shan-Chwen Chang;Hsueh P.-R.;Luh K.-T.;Chuang C.-Y.; Hsieh S.-M.; Hung C.-C.; Chen M.-Y.; SHAN-CHWEN CHANG; Hsueh P.-R.; Luh K.-T.; Chuang C.-Y. |
| 臺大學術典藏 |
2020-12-30T02:45:37Z |
Pattern of defervescence in response to anti-tuberculosis therapy in patients with extrapulmonary tuberculosis and advanced human immunodeficiency virus infection
|
Hsieh S.-M.;Sheng W.-H.;Chen M.-Y.;Hung C.-C.;Shan-Chwen Chang; Hsieh S.-M.; Sheng W.-H.; Chen M.-Y.; Hung C.-C.; SHAN-CHWEN CHANG |
| 臺大學術典藏 |
2020-12-30T02:45:34Z |
Successful discontinuation of secondary prophylaxis for histoplasmosis after higly active antiretroviral therapy
|
Sun H.-Y.; Chen M.-Y.; Hsieh S.-M.; Hung C.-C.; SHAN-CHWEN CHANG; Sun H.-Y.;Chen M.-Y.;Hsieh S.-M.;Hung C.-C.;Shan-Chwen Chang |
| 臺大學術典藏 |
2020-12-30T02:45:34Z |
Clinical features and outcome analysis of infective endocarditis in elderly patients
|
Wang J.-L.;Hung C.-C.;Hsieh S.-M.;Shan-Chwen Chang; Wang J.-L.; Hung C.-C.; Hsieh S.-M.; SHAN-CHWEN CHANG |
| 臺大學術典藏 |
2020-12-30T02:45:33Z |
Nosocomial bloodstream infection in human immunodeficiency virus-infected patients in Taiwan: Descriptive epidemiology and risk factors for mortality
|
Wang J.-T.;Sheng W.-H.;Chen M.-Y.;Fang C.-T.;Hsieh S.-M.;Hsueh P.-R.;Hung C.-C.;Shan-Chwen Chang; Wang J.-T.; Sheng W.-H.; Chen M.-Y.; Fang C.-T.; Hsieh S.-M.; Hsueh P.-R.; Hung C.-C.; SHAN-CHWEN CHANG |
| 臺大學術典藏 |
2020-12-30T02:45:28Z |
Late diagnosis of human immunodeficiency virus infection in the era of highly active antiretroviral therapy: Role of socio-behavioral factors and medical encounters
|
Lo Y.-C.;Wu P.-Y.;Hsieh C.-Y.;Chen M.-Y.;Sheng W.-H.;Hsieh S.-M.;Sun H.-Y.;Liu W.-C.;Hung C.-C.;Shan-Chwen Chang; Lo Y.-C.; Wu P.-Y.; Hsieh C.-Y.; Chen M.-Y.; Sheng W.-H.; Hsieh S.-M.; Sun H.-Y.; Liu W.-C.; Hung C.-C.; SHAN-CHWEN CHANG |
| 臺大學術典藏 |
2020-12-30T02:45:19Z |
Comparison of bone marrow studies with blood culture for etiological diagnosis of disseminated mycobacterial and fungal infection in patients with acquired immunodeficiency syndrome
|
Luh K.-T.; SHAN-CHWEN CHANG; Ker C.-C.;Hung C.-C.;Huang S.-Y.;Chen M.-Y.;Hsieh S.-M.;Lin C.-C.;Shan-Chwen Chang;Luh K.-T.; Ker C.-C.; Hung C.-C.; Huang S.-Y.; Chen M.-Y.; Hsieh S.-M.; Lin C.-C. |
| 臺大學術典藏 |
2020-12-30T02:44:28Z |
Response to efavirenz plus two nucleoside reverse-transcriptase inhibitors in patients with advanced stage human immunodeficiency virus-1 infection in Taiwan
|
Deng S.-C.;Chen M.-Y.;Hsieh S.-M.;Sheng W.-H.;Hsiao C.-F.;Hung C.-C.;Shan-Chwen Chang; Deng S.-C.; Chen M.-Y.; Hsieh S.-M.; Sheng W.-H.; Hsiao C.-F.; Hung C.-C.; SHAN-CHWEN CHANG |
| 臺大學術典藏 |
2020-12-30T02:44:27Z |
Discontinuation of secondary prophylaxis in AIDS patients with disseminated non-tuberculous mycobacteria infection
|
SHAN-CHWEN CHANG; Hung C.-C.; Sheng W.-H.; Liao C.-H.;Chen M.-Y.;Hsieh S.-M.;Sheng W.-H.;Hung C.-C.;Shan-Chwen Chang; Liao C.-H.; Chen M.-Y.; Hsieh S.-M. |
| 臺大學術典藏 |
2020-12-30T02:44:25Z |
Dose reduction for the management of indinavir-related toxicity in human immunodeficiency virus type 1-infected patients in Taiwan: Clinical and pharmacokinetic assessment
|
Pan S.-C.;Hsieh S.-M.;Hung C.-C.;Huang P.-F.;Chen M.-Y.;Shan-Chwen Chang; Pan S.-C.; Hsieh S.-M.; Hung C.-C.; Huang P.-F.; Chen M.-Y.; SHAN-CHWEN CHANG |
